Unlike the majority of solid tumors, in which high expression of p27Kip1 protein is linked with a favorable prognosis, the increased expression of this protein in CLL cells is associated with a more aggressive clinical course [28,30,31]. This evidence concerns the gene CDKN1B and B-cell chronic lymphocytic leukemia.